Lm-LLO-Based Immunotherapies and HPV-Associated Disease - Wikidata - awgldk - TriplyDB

Lm-LLO-Based Immunotherapies and HPV-Associated Disease

Lm-LLO-Based Immunotherapies and HPV-Associated Disease

http://www.wikidata.org/entity/Q35838127

about

Immunotherapy for head and neck cancer: latest developments and clinical potential An updated overview of HPV-associated head and neck carcinomas Novel Immunotherapeutic Approaches for Head and Neck Squamous Cell Carcinoma Anti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)-LLO immunotherapy.Mechanistic insights into ADXS11-001 human papillomavirus-associated cancer immunotherapy.The delicate balance in genetically engineering live vaccines.Therapeutic options for treatment of human papillomavirus-associated cancers - novel immunologic vaccines: ADXS11-001.ADXS-HPV: a therapeutic Listeria vaccination targeting cervical cancers expressing the HPV E7 antigen.Promising systemic immunotherapies in head and neck squamous cell carcinoma.Leveraging immunotherapy for the treatment of gynecologic cancers in the era of precision medicine Listeriolysin O as a strong immunogenic molecule for the development of new anti-tumor vaccines Cervical Cancer: Development of Targeted Therapies Beyond Molecular Pathogenesis.Immunologic treatments for precancerous lesions and uterine cervical cancer.The immune system and head and neck squamous cell carcinoma: from carcinogenesis to new therapeutic opportunities.Cervical Precancer Treatment in Low- and Middle-Income Countries: A Technology Overview.Highlights of the society for immunotherapy of cancer (SITC) 27th annual meeting.Engineering Vaccines to Reprogram Immunity against Head and Neck Cancer.A Randomized Phase 2 Study of ADXS11-001 Listeria monocytogenes-Listeriolysin O Immunotherapy With or Without Cisplatin in Treatment of Advanced Cervical Cancer.Emerging human papillomavirus vaccines

P2860

Q26745428-5E885E1E-8C90-4524-922D-34B486EC143C Q27014019-F06C0891-3130-4B7F-8C6F-DE5705FDC4DE Q28071998-D6C304B4-3A04-45DC-B809-FF407F0036DC Q33606111-4E32D66B-0098-4567-8CE9-0D2390A163BD Q33755840-D694C543-4FF2-45BC-864B-D7EF29E5A1D7 Q33801051-04131E71-4F07-4B5F-9EE0-D9ADF2B478F5 Q33908553-BE306598-33D6-41B5-8087-8CB666FFDF78 Q35886730-0C265705-FDED-4A7A-914D-FDBC3C4BBA88 Q36883848-69EC0870-AFE6-43F5-9470-C25889DC14CB Q37224420-6D3EF320-A5C8-49CA-A753-25D7B2EC1629 Q37505374-8495F967-F875-4E7E-9365-83DEBC2741E1 Q37579334-992CB6D8-9862-40D6-9010-18D08B3BB6AA Q37703113-6BA88126-10CC-4673-8744-6A1EAA3FB2C8 Q38161874-2BA6DD56-782D-42E3-971E-90E649387D19 Q41443004-741BD835-3DF4-4A10-96A2-F29EA11D6551 Q46507832-6F088909-F4C8-4F32-BB0A-6386E6D7D947 Q54256927-B59254DC-757A-48EF-AF19-9C031738AB2A Q55287181-C28A7B0B-1D88-4344-8CC9-7224CF9F8AAF Q56967486-C12455C2-B45C-40D1-B1D8-1934191D9D89

P2860

Lm-LLO-Based Immunotherapies and HPV-Associated Disease

http://www.wikidata.org/entity/Q35838127

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Lm-LLO-Based Immunotherapies and HPV-Associated Disease

@ast

Lm-LLO-Based Immunotherapies and HPV-Associated Disease

@en

type

label

Lm-LLO-Based Immunotherapies and HPV-Associated Disease

@ast

Lm-LLO-Based Immunotherapies and HPV-Associated Disease

@en

prefLabel

Lm-LLO-Based Immunotherapies and HPV-Associated Disease

@ast

Lm-LLO-Based Immunotherapies and HPV-Associated Disease

@en

P1433

Q35838127-0CF97D7C-311E-48BC-9BC1-2FDD8094E384

P1476

Q35838127-68EDAA77-9E6D-4B2D-A450-F7C512B2E5C6

P2093

Q35838127-16194872-0111-4B9B-9209-EAD44191E1A2

Q35838127-61C65A69-F539-47EE-9786-9B336A7A1547

Q35838127-79319AF0-7FA2-460A-A252-E50328E1A2E8

Q35838127-8CA5E7FB-F3C8-4CD4-AD1C-0290E34422C4

Q35838127-C0C15917-B120-4E6E-BC6E-5D60C05F30A9

Q35838127-D416CD77-9C6C-42F3-B76D-837363D16CA8

P2860

Q35838127-00B7E3AC-A816-48BF-A96D-37CCD0CAB8D1

Q35838127-016AE572-9E68-4AF3-BC54-3BA79A8E89FB

Q35838127-0706B702-81BC-4303-9947-14014699507A

Q35838127-07F5BBD3-462C-47B5-ADB5-E09A7492DE36

Q35838127-09B45356-B3EF-49C3-BEFF-43953F3DB562

Q35838127-1611E736-A7B3-4237-93E5-20E08B21597E

Q35838127-222F9763-D280-4E07-AF0A-3E1EF4814255

Q35838127-2581B301-B64A-486C-9E06-891ADCC88C94

Q35838127-25F848C6-72A3-4F94-9EE2-021D4D324B37

Q35838127-2655D879-CB6F-4BA8-BC16-C56456A9AA97

P304

Q35838127-08E91544-9B4F-48DA-8CA8-13E772EC7FC3

P31

Q35838127-E26AA3FA-4B8A-4B88-93E0-53F8B4BB26CF

P356

Q35838127-6B86F5E7-2F75-4979-95BE-3B34BB45784C

P478

Q35838127-218ACDEC-94BA-4885-8788-92B2428C5869

P577

Q35838127-E83E9312-B834-44DA-A6D0-668388B288C4

P5875

Q35838127-CB2C5D7C-AAEC-4DFB-8A3F-BCC45FFA414C

P698

Q35838127-E5BBE966-7C62-4601-8B7B-69CBFAA4CAFA

P932

Q35838127-C12C28E4-8388-4B00-B5E0-DCA76820E303

P356

P1433

Journal of oncology

P1476

Lm-LLO-Based Immunotherapies and HPV-Associated Disease

@en

P2093

Anu Wallecha

http://www.w3.org/2001/XMLSchema#string

Ashok Amin

http://www.w3.org/2001/XMLSchema#string

Chris French

http://www.w3.org/2001/XMLSchema#string

John Rothman

http://www.w3.org/2001/XMLSchema#string

Reshma Singh

http://www.w3.org/2001/XMLSchema#string

Robert Petit

http://www.w3.org/2001/XMLSchema#string

P2860

Listeriolysin O: a genuine cytolysin optimized for an intracellular parasite

The global health burden of infection-associated cancers in the year 2002

Case-control study of human papillomavirus and oropharyngeal cancer

Papillomaviruses and cancer: from basic studies to clinical application

Genomewide gene expression profiles of HPV-positive and HPV-negative oropharyngeal cancer: potential implications for treatment choices

Visualizing early splenic memory CD8+ T cells reactivation against intracellular bacteria in the mouse

Listeria monocytogenes virulence factors that stimulate endothelial cells.

Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8(+) T-cell responses that home to the tumor site

Listeria pathogenesis and molecular virulence determinants

Cancer immunotherapy using recombinant Listeria monocytogenes: transition from bench to clinic.

P304

542851

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2012/542851

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223963359

http://www.w3.org/2001/XMLSchema#string

P698

22481930

http://www.w3.org/2001/XMLSchema#string

P932

3307007

http://www.w3.org/2001/XMLSchema#string